Enhancement of insulin transport across primary rat alveolar epithelial cell monolayers by endogenous cellular factor(s)

Pharmaceutical Research

Volumn 24, Issue 9, 2007, Pages 1713-1719

  Bahhady, Rana ^a   Kim, Kwang Jin ^a,b   Borok, Zea ^a,b   Crandall, Edward D ^a,b   Shen, Wei Chiang ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alveolar epithelial cell monolayer; Conditioned medium; Insulin; Transport

Indexed keywords

AMMONIUM SULFATE; CARBON 14; HORSERADISH PEROXIDASE; INSULIN; KERATINOCYTE GROWTH FACTOR; MANNITOL;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DENATURATION; DRUG ABSORPTION; DRUG TRANSPORT; HEAT; INCUBATION TIME; ISOTOPE LABELING; LUNG ALVEOLUS EPITHELIUM; MOLECULAR SIZE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; EPITHELIAL CELLS; INSULIN; IODINE RADIOISOTOPES; PROTEASE INHIBITORS; PULMONARY ALVEOLI; RATS; TEMPERATURE;

EID: 34547624130     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9301-9     Document Type: Article

References (35)

1. J. S. Patton, J. Bukar, and S. Nagarajan. Inhaled insulin. Adv. Drug Deliv. Rev. 35:235-247 (1999).
2. F. W. Wigley, J. H. Londono, S. H. Wood, J. C. Shipp, and R. H. Waldman. Insulin across respiratory mucosae by aerosol delivery. Diabetes 20:552-556 (1971).
3. J. S. Patton, C. S. Fishburn, and J. G. Weers. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1:338-344 (2004).
4. J. S. Patton. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 19:3-36 (1996).
5. A. Yamamoto, S. Umemori, S. Muranishi and S. Muranishi. Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats. J. Pharm. Pharmacol. 46:14-18 (1994).
6. F. Komada, S. Iwakawa, F. N. Yamamoto, H. Sakakibara, and K. Okumura. Intratracheal delivery of insulin: absorption from solution and aerosol by rat lung. Int. J. Pharm. 88:63-73 (1992).
7. F. Johansson, E. Hjertberg, S. Eirefelt, A. Tronde, and U. Hultkvist Bengtsson. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate. Eur. J. Pharm. Sci. 17:63-71 (2002).
8. L. Li, N. R. Mathias, C. L. Heran, P. Moench, D. A. Wall, and R. L. Smith. Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers. J. Pharm. Sci. 95:326-335 (2006).
9. Y. Fukuda, T. Tsuji, T. Fujita, A. Yamamoto, and S. Muranishi. Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors. Biol. Pharm. Bull. 18:891-894 (1995).
10. Z. Shen, Q. Zhang, S. Wei, and T. Nagai. Proteolytic enzymes as a limitation for pulmonary absorption of insulin: in vitro and in vivo investigations. Int. J. Pharm. 192:115-121 (1999).
11. S. Kobayashi, S. Kondo, and K. Juni. Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers. Pharm. Res. 11:239-1243 (1994).
12. A. J. Bitonti, J. A. Dumont, S. C. Low, R. T. Peters, K. E. Kropp, V. J. Palombella, J. M. Stattel, Y. Lu, C. A. Tan, J. J. Song, A. M. Garcia, N. E. Simister, G. M. Spiekermann, W. I. Lencer, and R. S. Blumberg. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc. Natl. Acad. Sci. USA 101:9763-9768 (2004).
13. A. J. Bitonti and J. A. Dumont. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Adv. Drug Deliv. Rev. 58:1106-1118 (2006).
14. A. Widera, K. J. Kim, E. D. Crandall, and W. C. Shen. Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers. Pharm. Res. 20:1231-1238 (2003).
15. D. Deshpande, D. Toledo-Velasquez, L. Y. Wang, C. J. Malanga, J. K. Ma, and Y. Rojanasakul. Receptor-mediated peptide delivery in pulmonary epithelial monolayers. Pharm. Res. 11:1121-1126 (1994).
16. M. E. Brandes and J. N. Finkelstein. Stimulated rabbit alveolar macrophages secrete a growth factor for type II pneumocytes. Am. J. Respir. Cell Mol. Biol. 1:101-109 (1989).
17. Y. Matsukawa, H. Yamahara, F. Yamashita, V. H. Lee, E. D. Crandall, and K. J. Kim. Rates of protein transport across rat alveolar epithelial cell monolayers. J. Drug Target. 7:335-342 (2000).
18. M. Bur, H. Huwer, C. M. Lehr, N. Hagen, M. Guldbrandt, K. J. Kim, and C. Ehrhardt. Assessment of transport rates of proteins and peptides across primary human alveolar epithelial cell monolayers. Eur. J. Pharm. Sci. 28:196-203 (2006).
19. Z. Borok, R. L. Lubman, S. I. Danto, X. L. Zhang, S. M. Zabski, L. S. King, D. M. Lee, P. Agre, and E. D. Crandall. Keratinocyte growth factor modulates alveolar epithelial cell phenotype in vitro: expression of aquaporin 5. Am. J. Respir. Cell Mol. Biol. 18:554-561 (1998).
20. R. Mitra, I. Pezron, Y. Li, and A. K. Mitra. Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids. Int. J. Pharm. 217:25-31 (2001).
21. P. J. McConahey and F. J. Dixon. Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol. 70:210-213 (1980).
22. V. Herzog and H. D. Fahimi. A new sensitive colorimetric assay for peroxidase using 3,3′-diaminobenzidine as hydrogen donor. Anal. Biochem. 55:554-562 (1973).
23. A. Hussain, J. J. Arnold, M. A. Khan, and F. Ahsan. Absorption enhancers in pulmonary protein delivery. J. Control. Release 94:15-24 (2004).
24. T. Y. Ma, D. Nguyen, V. Bui, H. Nguyen, and N. Hoa. Ethanol modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. 276:G965-G974 (1999).
25. V. A. K. Dodane, M. Amin Khan, and J. R. Merwin. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 10:21-32 (1999).
26. M. Machida, M. Hayashi, and S. Awazu. The effects of absorption enhancers on the pulmonary absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats. Biol. Pharm. Bull. 23:84-86 (2000).
27. T. Morita, A. Yamamoto, Y. Takakura, M. Hashida, and H. Sezaki. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats. Pharm. Res. 11:909-913 (1994).
28. B. Forbes, C. G. Wilson, and M. Gumbleton. Temporal dependence of ectopeptidase expression in alveolar epithelial cell culture: implications for study of peptide absorption. Int. J. Pharm. 180:225-234 (1999).
29. M. C. Hsu and J. P. Bai. Investigation into the presence of insulin-degrading enzyme in cultured type II alveolar cells and the effects of enzyme inhibitors on pulmonary bioavailability of insulin in rats. J. Pharm. Pharmacol. 50:507-514 (1998).
30. S. Y. Hirai, T. Yashiki, and H. Mima. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9:173-184 (1981).
31. G. S. Gordon, A. C. Moses, R. D. Silver, J. S. Flier, and M. C. Carey. Nasal absorption of insulin: enhancement by hydrophobic bile salts. Proc. Natl. Acad. Sci. USA 82:7419-7423 (1985).
32. R. H. Hastings, H. G. Folkesson, and M. A. Matthay. Mechanisms of alveolar protein clearance in the intact lung. Am. J. Physiol. 286:L679-L689 (2004).
33. D. Shah and W. C. Shen. The paradox of transferrin receptor-mediated drug delivery-intracellular targeting or transcellular transport? J. Drug Target. 3:243-245 (1995).
34. L. G. Dobbs, M. C. Williams, and A. E. Brandt. Changes in biochemical characteristics and pattern of lectin binding of alveolar type II cells with time in culture. Biochim. Biophys. Acta 846:155-166 (1985).
35. M. Sakagami. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv. Drug Deliv. Rev. 58:1030-1060 (2006).